首页> 中文期刊>国际医药卫生导报 >2006-2008年我院抗糖尿病药物临床应用分析

2006-2008年我院抗糖尿病药物临床应用分析

摘要

Objective Statistics of the antidiabetic drugs in our hospital the clinical application of data,and analysis of clinical application of hypoglycemic drug trends was done.Methods From 2006 to 2008 by application of the hypoglycemic drug variety,amount and frequency of use(DDDs)and other data were statistically analyzed.Results The anti-diabetic drugs sales showed an upward trend year after year,its share of drugs in our hospital the proportion of the total amount of sales was also an upward trend year after year.Among them,the insulin-type drugs,anti-diabetic drug sales in the largest proportion of,and has increased year by year.Novolin 30R and the sales amount of DDDs in-the 3 years are among the first sort.Conclusions The anti-diabetic drugs,the demand for year-on-year growth,including insulin drugs,α-glucosidase inhibitor and insulin secretion promoting agent is a clinical application in our hospital as the main hypoglycemic drugs.%目的 统计我院抗糖尿病药物的临床应用数据,分析降糖药物临床应用的发展趋势.方法 对我院2006-2008年所应用的降糖药物品种、金额和用药频度(DDDs)等数据进行统计学分析.结果 抗糖尿病类药物的销售金额呈逐年上升趋势,其所占我院药品销售总金额的比例亦呈逐年上升趋势.其中,胰岛素类药物的销售在抗糖尿病药物中的比例最大,且逐年增加.诺和灵30R的销售金额及其DDDs在3年中排序均佗列第一位.结论 抗糖尿病药物的需求逐年增长,其中胰岛素类药物、α-葡萄糖苷酶抑制剂和促胰岛素分泌剂是我院临床应用的主要降糖药物.

著录项

相似文献

  • 中文文献
  • 外文文献
  • 专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号